Cargando…
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects
Bile acid synthesis defects (BASDs) comprise a group of rare diseases that can be severely disabling. Bile acid supplementation with 5 to 15 mg/kg cholic acid (CA) has been hypothesized to decrease endogenous bile acid production, stimulate bile secretion, and improve bile flow and micellar solubili...
Autores principales: | Polak, Yasmin, Jacobs, Bart A. W., Bouwhuis, Natalja, Hollak, Carla E. M., Kroon, Maurice A. G. M., Kemper, Elles Marleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059964/ https://www.ncbi.nlm.nih.gov/pubmed/36986634 http://dx.doi.org/10.3390/pharmaceutics15030773 |
Ejemplares similares
-
Product development and quality of pharmacy compounded chenodeoxycholic acid capsules for Dutch cerebrotendinous xanthomatosis patients
por: Bouwhuis, Natalja, et al.
Publicado: (2023) -
Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid
por: Polak, Yasmin, et al.
Publicado: (2021) -
Cholic acid therapy in Zellweger spectrum disorders
por: Berendse, Kevin, et al.
Publicado: (2016) -
Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders
por: Heubi, James E., et al.
Publicado: (2017) -
Validation of Recombinant Chicken Liver Bile Acid Binding Protein as a Tool for Cholic Acid Hosting
por: Tassone, Giusy, et al.
Publicado: (2021)